CardioGenics Holdings Inc (OTCMKTS:CGNH – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares trading hands.
CardioGenics Price Performance
CardioGenics Company Profile
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Stories
- Five stocks we like better than CardioGenics
- What is a Bond Market Holiday? How to Invest and Trade
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- How to Effectively Use the MarketBeat Ratings Screener
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Government Mandate Sends eVTOL Stocks Flying
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.
